150 related articles for article (PubMed ID: 33264210)
21. Treatment Outcomes in Infections Caused by "SPICE" (Serratia, Pseudomonas, Indole-positive Proteus, Citrobacter, and Enterobacter) Organisms: Carbapenem versus Noncarbapenem Regimens.
Moy S; Sharma R
Clin Ther; 2017 Jan; 39(1):170-176. PubMed ID: 28034519
[TBL] [Abstract][Full Text] [Related]
22. Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae.
Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler MK; Tolomeo P; Han JH;
Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1431-1435. PubMed ID: 30375298
[TBL] [Abstract][Full Text] [Related]
23. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
[TBL] [Abstract][Full Text] [Related]
24. Bacterial Resistance to Cephalosporin Treatment in Elderly Stable Patients Hospitalized With a Urinary Tract Infection.
Shimoni Z; Salah M; Kasem A; Hermush V; Froom P
Am J Med Sci; 2020 Sep; 360(3):243-247. PubMed ID: 32482350
[TBL] [Abstract][Full Text] [Related]
25. Combined Molecular and Phenotypic Antimicrobial Susceptibility Testing Is Beneficial in Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of Enterobacteriaceae in Pediatric Patients with Bloodstream Infections.
Powell EA; Khalil N; DeBurger B; Mortensen JE
Microb Drug Resist; 2020 Jul; 26(7):825-830. PubMed ID: 32181692
[No Abstract] [Full Text] [Related]
26. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
[TBL] [Abstract][Full Text] [Related]
27. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital.
Lim CL; Spelman D
Infect Dis Health; 2019 Aug; 24(3):124-133. PubMed ID: 30928569
[TBL] [Abstract][Full Text] [Related]
28. Enterobacteriaceae resistant to third generation cephalosporins upon hospital admission: risk factors and clinical outcomes.
Oliveira MC; Oliveira CR; Gonçalves KV; Santos MS; Tardelli AC; Nobre VA
Braz J Infect Dis; 2015; 19(3):239-45. PubMed ID: 25892313
[TBL] [Abstract][Full Text] [Related]
29. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G
FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
Goossens H; Grabein B
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
[TBL] [Abstract][Full Text] [Related]
31. Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
Jones RN
Diagn Microbiol Infect Dis; 1998 Jul; 31(3):461-6. PubMed ID: 9635237
[TBL] [Abstract][Full Text] [Related]
32. Performance of a novel fluorogenic chimeric analog for the detection of third-generation cephalosporin resistant bacteria.
Park MJ; Park YJ; Oh EJ; Chang J; Kim Y; Yu J; Park KG; Ahn DR
J Microbiol Methods; 2016 Dec; 131():161-165. PubMed ID: 27784641
[TBL] [Abstract][Full Text] [Related]
33. Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.
Kohlmann R; Bähr T; Gatermann SG
J Antimicrob Chemother; 2018 Jun; 73(6):1530-1536. PubMed ID: 29566147
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for third-generation cephalosporin resistant Enterobacteriaceae in gestational urine cultures: A retrospective cohort study based on centralized electronic health records.
Guri A; Flaks-Manov N; Ghilai A; Hoshen M; Flidel Rimon O; Ciobotaro P; Zimhony O
PLoS One; 2020; 15(1):e0226515. PubMed ID: 31899777
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
Tan SH; Ng TM; Chew KL; Yong J; Wu JE; Yap MY; Heng ST; Ng WHW; Wan S; Cheok SJH; Tambyah PA; Lye DC
Int J Antimicrob Agents; 2020 Feb; 55(2):105860. PubMed ID: 31841674
[TBL] [Abstract][Full Text] [Related]
36. ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage.
van den Bunt G; Liakopoulos A; Mevius DJ; Geurts Y; Fluit AC; Bonten MJ; Mughini-Gras L; van Pelt W
J Antimicrob Chemother; 2017 Feb; 72(2):589-595. PubMed ID: 27789683
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Cheong HS; Ko KS; Kang CI; Chung DR; Peck KR; Song JH
Microb Drug Resist; 2012 Aug; 18(4):446-52. PubMed ID: 22409779
[TBL] [Abstract][Full Text] [Related]
38. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
[TBL] [Abstract][Full Text] [Related]
39. Analysis of AmpC beta-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae from paediatric patients.
Avison MB; Underwood S; Okazaki A; Walsh TR; Bennett PM
J Antimicrob Chemother; 2004 Apr; 53(4):584-91. PubMed ID: 15014062
[TBL] [Abstract][Full Text] [Related]
40. Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India.
Bharadwaj R; Robinson ML; Balasubramanian U; Kulkarni V; Kagal A; Raichur P; Khadse S; Kadam D; Valvi C; Kinikar A; Kanade S; Suryavanshi N; Marbaniang I; Nelson G; Johnson J; Zenilman J; Sachs J; Gupta A; Mave V
BMC Infect Dis; 2018 Oct; 18(1):504. PubMed ID: 30286741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
